Nationell upphandling PD-(L)1-hämmare 2027

Summary

Region Stockholm is conducting a national framework agreement tender for PD-(L)1 inhibitors (cancer medications) valued at approximately 2.8 billion SEK. Pharmaceutical suppliers of medicines in the ATC group L01FF may apply in an open procedure with a deadline of 2 November 2026. The framework agreement is national and covers prescription medications; only registered pharmaceutical suppliers with approved documentation can realistically qualify. This is a strategic procurement for oncology medicines with an extended implementation period.